50 likes | 63 Views
The human microbiome market is expected to reach US$ 2,921.68 million by 2028 from US$ 718.95 million in 2021; it is estimated to grow at a CAGR of 22.2% during 2021u20132028. The human microbiota consists of the trillions of symbiotic microbial cells harbored by each person mainly bacteria in the gut. <br><br>Get Free Sample PDF - https://www.theinsightpartners.com/sample/TIPBT00002233/
E N D
Human Microbiome Market Human Microbiome Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others) and Application (Therapeutics and Diagnostics) and Geography
Human Microbiome Market Current and future MarketScenario • According to our new market research study on “Human Microbiome Market to 2028 – Global Analysis and Forecast – by Type, Treatment, and End User,” the market is expected to reach US$ 3,653.92 million by 2028 from US$ 2,541.07 million in 2019.
Human Microbiome Market MarketSegments By Product Probiotics Foods Prebiotics Medical Foods Diagnostic Device Drugs and Supplements Disease Obesity Diabetes Autoimmune Disorders Cancer Mental Disorders and Others Application Therapeutics Diagnostics
Human Microbiome Market LeadingPlayers Company Profiles in Human Microbiome Market are: Rebiotix Inc. Yakult Honsha Co., Ltd. Synthetic Biologics Inc. DuPont MaaT Pharma Eligo Bioscience Merck & Co. Inc AOBiome LLC Kaleido Seres Therapeutics
Human Microbiome Market Access Full Research Report at: https://www.theinsightpartners.com/reports/human-microbiome-market Thank You! Thank You!